The Pulmonary Injury and Repair Center at the University of Alabama at Birmingham has produced a major return on investment in its six years of existence. The Center, begun in 2008 with an initial investment of $140,000 from the UAB School of Medicine, Department of Anesthesiology and Southern Research Institute, has since received nearly $10 million in research funding from government and industry sources.
Those funds have spurred scientific research, recruited new faculty and produced new knowledge in treating lung injury, especially from chemical agents such as chlorine, ammonia and bromine.
Chlorine, ammonia and bromine are commonly used in various industrial applications and are routinely shipped across the country. Exposure to these agents could come as a result of a deliberate terror attack or from an inadvertent leak from a transportation mishap.
“Inhalation of these gases can cause extreme, possibly fatal injury to the lungs,” said Sadis Matalon, Ph.D., distinguished professor and vice chair for research in the Department of Anesthesiology, and director of the center. “Our research is geared toward finding countermeasures that could be employed to minimize pulmonary injury in the event of a chlorine, ammonia or bromine release, whatever the cause may be.”
The UAB center is part of the federal government’s CounterACT Program. Funded by the National Institutes of Health, CounterACT is a translational research program aimed at the discovery and/or identification of better therapeutic medical countermeasures and technologies against chemical threat agents. CounterACT was launched following the terror attacks on Sept. 11, 2001, as awareness grew of potential threats from chemical agents.
UAB is one of the few research institutions in the nation involved in countermeasure research against chlorine and ammonia, and it is the only site looking for agents that would be effective against bromine, according to Matalon.
“We are investigating multiple strategies to respond to lung injury in the event of exposure to these agents,” Matalon said. “We have identified compounds that in preliminary studies have been shown to prevent death after chlorine exposure, for example. Compounds such as antioxidants and nitrites also have promise in reducing or reversing the toxic effects of these agents.”
Matalon says one of the center’s strengths is its reach across the breadth of UAB. Investigators involved in the major projects come from multiple disciplines and include Victor Darley-Usmar, Ph.D., and Jianhua Zhang, Ph.D., pathology; Tim Ness, M.D., anesthesiology; Chad Steele, Ph.D., and Veena Antony, M.D., pulmonary medicine; Rakesh Patel, Ph.D., molecular and cellular pathology; Mohammad Athar, dermatology; and Anupam Agarwal, M.D., nephrology. Other prominent investigators include Edward Postlethwait, Ph.D., Michelle Fanucchi, Ph.D., and Giuseppe Squadrito, Ph.D., in the School of Public Health; as well as James and Diana Noah, Ph.D.s, with Southern Research Institute.
Matalon and Darley-Usmar received a grant to test the role of mitochondrial injury in the initiation and propagation of chlorine injury to the lungs. Matalon is also collaborating with Sven Eric Jordt, Ph.D., of Yale University, to test the effectiveness of a new class of anti-inflammatory agents to decrease chlorine injury.
Patel was recently funded by the CounterACT Program to test the efficacy of nitrites to decrease mortality and lung injury in chlorine-exposed animals. Athar is funded by CounterACT to develop therapeutic interventions of lewisite-mediated injury to the skin, which could contribute to lung injury. Ness was also funded to investigate whether local anesthetics administered post-exposure reduce pain.
“This is a critical issue because people who experience pain have decreased ability to walk away from the epicenter of a chemical attack,” Matalon said.
The center also played a role in the recruitment of prominent new faculty to UAB, says Matalon, including Victor Thannickal, M.D., chair of the Division of Pulmonary, Allergy and Critical Care Medicine, and Jean-Francois Pittet, M.D., professor of anesthesiology.
“The Pulmonary Injury and Repair Center has enhanced collaborations among basic and clinical investigators at UAB and has driven translational research in lung injury and repair,” Matalon said. “It has also strengthened existing interactions among researchers from UAB and Southern Research Institute. These interactions continue to improve our ability to attract new faculty interested in pulmonary research at UAB and to compete for extramural awards.”
White House strategist to lead UAB’s Personalized Medicine InstituteMatt Might, Ph.D., a strategic leader in the White House Precision Medicine Initiative, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at UAB.posted yesterday 321 viewsUAB developing new peptide to combat a disorder that causes heart attacks at early ageSome people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.posted 2 days ago 1444 viewsArea middle schoolers to learn about STEM at UABThe event will be offered over two days in February, and will also include a parent/educator workshop this year.posted 6 days ago 343 viewsUAB to bring proton therapy for advanced cancer treatment to BirminghamUAB will bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama with the new Proton Therapy Center.posted 7 days ago 6487 viewsUsing protons to fight cancer: the science behind the UAB Proton CenterA 90-ton machine called a cyclotron will accelerate protons to very high speeds to impact human tumors.posted 7 days ago 2178 viewsGARP2 accelerates retinal degeneration in a mouse modelThe function and structure of protein GARP2 in rod cells of the retina is still not clear, but researchers have shown that GARP2 accelerates retinal degeneration in mice, and have made an important step toward creating a standardized nomenclature between mice and humans for a measurement of retinal degeneration.posted 8 days ago 812 viewsDothan man sees improvement in quality of life after LVAD surgeryJames Ward could not walk from his office to his car without having trouble breathing until a life-changing heart pump gave him hope.posted 9 days ago 7248 viewsDrivers can now charge electric vehicles on campus at UABDrivers of electric vehicles can now charge their cars at electronic vehicle service equipment ports on UAB’s campus.posted 10 days ago 854 viewsPeruvian native to lead top global tropical medicine training center at UABUAB names new leadership for Gorgas Center for Geographic Medicine.posted 10 days ago 1093 views7-year-old Suki Bateh inspires UAB and Children’s to create Sarah Katherine Bateh Endowed Professorship in Rett SyndromeThe Suki Foundation, Children’s of Alabama and UAB have established an endowed professorship in Rett syndrome.posted 13 days ago 10730 viewsUAB pulmonary investigators receive major NIH research grantsThree UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.posted 13 days ago 2515 viewsUAB first in Alabama to implement new FDA-approved PFO occluderMassoud Leesar, M.D., performed the first procedure Jan. 25, 2017, and that is good news for people who suffer strokes as a result of patent foramen ovale, or PFO.posted 14 days ago 909 viewsA “release and kill” strategy may aid treatment of tuberculosisTuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.posted 15 days ago 1428 viewsTwo global health case competitions to be hosted by UAB Sparkman Center for Global HealthUAB Sparkman Center for Global Health hosts global health case competitions for UAB students and students from across the state. Multidisciplinary teams propose innovative recommendations to a global health issue.posted 17 days ago 1435 views2017 Darwin Day commemorates Charles Darwin’s birthday, showcases scientific research
Poster sessions and guest lecturers aim to celebrate Darwin’s legacy.
Standard therapy used in pediatric cardiac ICU challenged by study in NEJMUAB researchers looked at body cooling versus normal temperature control in pediatric patients who suffered cardiac arrest in the hospital to find that neither is more beneficial.posted 20 days ago 1110 viewsBrain plasticity: How adult-born neurons get wired-inIt appears that new cells compete to ‘win’ synapse connections away from old cells, which promotes network plasticity.posted 21 days ago 2574 viewsUAB study shows children and parents over-report leukemia medication adherenceResearch from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.posted 21 days ago 1434 viewsJia Cui wins graduate travel award from the American Society for Biochemistry and Molecular BiologyThe award recognizes a significant paper by Cui in Cell Death and Differentiation.posted 24 days ago 1181 viewsNEJM lauds UAB study as one of the top neurology stories of 2016A UAB study confirming the efficacy of surgical removal of the thymus for patients with myasthenia gravis was cited as one of the top neurology stories of the year by the New England Journal of Medicine.posted 27 days ago 2987 views
- Event Date February 9